M, M., A, C., X, L., EC, K., & C, B. (2022). Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry. The Journal of rheumatology, 49(5), 447. https://doi.org/10.3899/jrheum.211066
Chicago Style (17th ed.) CitationM, Movahedi, Cesta A, Li X, Keystone EC, and Bombardier C. "Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry." The Journal of Rheumatology 49, no. 5 (2022): 447. https://doi.org/10.3899/jrheum.211066.
MLA (9th ed.) CitationM, Movahedi, et al. "Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry." The Journal of Rheumatology, vol. 49, no. 5, 2022, p. 447, https://doi.org/10.3899/jrheum.211066.